文献速递主动脉疾病

肾下腹主动脉瘤患者开放修复术适应性的评估

Assessment of fitness for open repair in patients with infrarenal abdominal aortic aneurysms.
PubMed 文献 · J Vasc Surg · 2024-04-11

本研究基于血管质量倡议数据库2003至2022年数据,将外科医生判定不适合开放修复而接受EVAR的肾下腹主动脉瘤患者与匹配的开放修复患者进行比较。结果显示开放修复组主要不良心脏事件、肺部并发症、非家庭出院和30天死亡率更高,但5年中期和远期生存更好;EVAR后需再干预者死亡风险显著升高。作者认为「不适合开放手术」的分类可能不准确,应重新评估该术语和概念。

要点

  • EVAR组匹配3028例(57.0%),开放组主要不良心脏事件20.2% vs 4.4%、30天死亡率4.5% vs 1.4%,均以开放组更高。
  • 开放修复组5年中期和远期生存优于EVAR组,早期生存无差异。
  • EVAR后需再干预者1年死亡率40.5% vs 未再干预者7.3%,5年死亡率43.2% vs 14.1%。

核心结论

  • 被判定不适合开放修复而接受EVAR的腹主动脉瘤患者围手术期并发症和死亡率优于开放修复,但开放修复组5年中期和远期生存更好。
  • 作者认为「不适合开放手术」的分类可能不准确,应重新评估该术语和概念。

研究设计与样本

  • 基于血管质量倡议(Vascular Quality Initiative)数据库2003至2022年数据的匹配队列研究。
  • 共识别5310例被判定不适合开放修复而接受EVAR的患者,其中3028例(57.0%)与开放修复患者按1:1匹配。
  • 排除因敌意腹腔而不适合开放修复的EVAR患者,以及非择期修复或既往有主动脉手术的患者。

主要发现

  • 开放组主要不良心脏事件20.2% vs EVAR组4.4%(P < .001),肺部并发症12.8% vs 1.6%(P < .001),非家庭出院28.5% vs 7.9%(P < .001),30天死亡率4.5% vs 1.4%(P < .001)。
  • 早期生存无差异,但开放修复组5年中期和远期生存优于EVAR组。
  • 研究期间共有74例EVAR患者(2.4%)接受再干预。
  • EVAR再干预者1年死亡率40.5% vs 未再干预者7.3%(P < .001),5年死亡率43.2% vs 14.1%(P < .001)。
  • EVAR再干预者1年死亡率40.5% vs 匹配开放组6.3%(P < .001),5年死亡率43.2% vs 匹配开放组20.3%(P = .006)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endovascular aortic repair (EVAR) was originally designed as a treatment modality for patients with abdominal aortic aneurysms (AAAs) deemed unfit for open repair. However, the definition of "unfit for open repair" is largely subjective and heterogenous. The purpose of this study was to compare patients deemed unfit for open repair who underwent EVAR to a matched cohort who underwent open repair for infrarenal AAAs. METHODS: The Vascular Quality Initiative of the Society for Vascular Surgery was queried for patients who underwent EVAR and open infrarenal AAA repair from 2003 to 2022. Patients that underwent EVAR were included if they were deemed unfit for open repair by the operating surgeon. EVAR patients deemed unfit because of a hostile abdomen were excluded. Patients in both the open and EVAR datasets were excluded if their repair was deemed non-elective or if they had prior aortic surgery. EVAR patients were matched to a cohort of open patients. The primary outcome for this study was 1-year mortality. Secondary outcomes included 30-day mortality, major adverse cardiac events, pulmonary complications, non-home discharge, reinterventions, and 5-year survival. RESULTS: A total of 5310 EVAR patients were identified who were deemed unfit for open repair. Of those, 3028 EVAR patients (57.0%) were able to be matched 1:1 to a cohort of open patients. Open patients had higher rates of major adverse cardiac events (20.2% vs 4.4%; P < .001), pulmonary complications (12.8% vs 1.6%; P < .001), non-home discharges (28.5% vs 7.9%; P < .001), and 30-day mortality (4.5% vs 1.4%; P < .001). There were no differences in early survival, but open repair had better middle and late survival compared with EVAR over the course of 5 years. A total of 74 EVAR patients (2.4%) had reinterventions during the study period. EVAR patients that required interventions had higher 1-year (40.5% vs 7.3%; P < .001) and 5-year mortality (43.2% vs 14.1%; P < .001) compared with those that did not require reinterventions. EVAR patients who had reinterventions had higher 1-year (40.5% vs 6.3%; P < .001) and 5-year (43.2% vs 20.3%; P = .006) mortality compared with their matched open cohort. CONCLUSIONS: Patients undergoing EVAR for AAAs who are deemed unfit for open repair have better perioperative morbidity and mortality compared with open repair. However, patients who had an open repair had better middle and late survival over the course of 5 years. The categorization of unfitness for open surgery may be inaccurate and re-evaluation of this terminology/concept should be undertaken.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Khoury MK, Thornton MA, Eagleton MJ, et al. Assessment of fitness for open repair in patients with infrarenal abdominal aortic aneurysms. J Vasc Surg. 2024. PMID: 38614140. doi:10.1016/j.jvs.2024.04.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。